Natera Launches Fetal RhD NIPT Supporting Ob/Gyn Physicians and Patients During RhIg Shortage

By /

Natera, Inc., a global leader in cell-free DNA and genetic testing, announced the launch of a new cfDNA-based fetal RhD test.

Scroll to Top